INS and cancer: The pathways exclusively represented by the upregulated genes at 3 h treatment include ‘glycolysis/gluconeogenesis’, ‘bisphenol degradation’ and that represented by upregulated genes at 6 h treatment include ‘proteoglycans in cancer’, ‘lysine degradation’, ‘insulin signaling pathway’.